Trial intelligence / Profile preview

Anticath: Povidone Iodine vs Chlorhexidine for CVC Disinfection

NCT00259350Phase 4Completed

Sponsor
CHU de Poitiers
Start
May 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of chlorhexidine, benzalkonium chloride, benzyl alcohol and povidone-iodine in catheter infection (2 arms), sponsored by CHU de Poitiers. Primary endpoint: Prevention of catheter colonization. Started May 2004; status: completed.

02

Drugs

chlorhexidinebenzalkonium chloridebenzyl alcoholpovidone-iodine
03

Conditions

catheter infection

Beyond the preview

Go deeper on NCT00259350.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00259350.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call